CAMP, cathelicidin antimicrobial peptide, 820

N. diseases: 262; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0243026
Disease: Sepsis
Sepsis
0.250 Biomarker disease BEFREE LL-37 Exacerbates Local Inflammation in Sepsis-Induced Acute Lung Injury by Preventing Mitochondrial DNA (mtDNA) Degradation-Induced Autophagy. 31422413 2019
CUI: C0243026
Disease: Sepsis
Sepsis
0.250 Biomarker disease BEFREE The authors previously revealed that LL‑37 improves the survival of a murine cecal ligation and puncture (CLP) sepsis model. 28849130 2017
CUI: C0243026
Disease: Sepsis
Sepsis
0.250 Biomarker disease BEFREE In fact, administration of citrullinated LL-37 plus endotoxin actually exacerbated sepsis due to the inability of LL-37 to neutralize LPS and the subsequent enhancement of systemic inflammation due to increased serum levels of IL-6. 24771854 2014
CUI: C0243026
Disease: Sepsis
Sepsis
0.250 Biomarker disease BEFREE SIC 1.84 bound both human and murine cathelicidins and was necessary and sufficient to promote covS mutant M1T1 GAS resistance to LL-37, growth in human whole blood and virulence in a murine model of systemic infection. 20814187 2010
CUI: C0243026
Disease: Sepsis
Sepsis
0.250 Biomarker disease RGD Lysozyme-modified probiotic components protect rats against polymicrobial sepsis: role of macrophages and cathelicidin-related innate immunity. 17142779 2006
CUI: C0243026
Disease: Sepsis
Sepsis
0.250 Biomarker disease BEFREE We propose that the natural human host defense peptide LL-37 plays roles in the delicate balancing of inflammatory responses in homeostasis as well as in combating sepsis induced by certain TLR agonists. 16456005 2006